Skip to content

USG Brachial Plexus Block for Upper Extremity Surgery

Ultrasound-guided Brachial Plexus Block With the Single-penetration Multiple-injection-technique for Upper Extremity Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01993290
Enrollment
120
Registered
2013-11-25
Start date
2013-04-30
Completion date
2015-06-30
Last updated
2015-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome, Fracture at Wrist and/or Hand Level, Ganglion Cysts, Injuries to the Wrist, Hand and Fingers (S60-S69), Rupture of Tendon of Wrist and Hand

Brief summary

Ultrasound-guided (USG) brachial plexus (BP) block efficacy at the Supraclavicular (SCL), Lateral- Infraclavicular (LIC) and Axillary (AX) level: Randomized, observer-blinded study of the single-penetration multiple-injection-technique.

Detailed description

The investigators will compare the BP block efficacy (for surgical anaesthesia) with the USG single-penetration multiple-injection-technique at the SCL, LIC and AX level for upper-extremity surgery (elbow, forearm, wrist, hand). The investigators want to investigate whether the single-penetration multiple-injection-technique would provide for safe surgical anaesthesia with lower volumes of local anaesthetics than has previously been described in a comparative study at the three different levels. 120 patients will prospectively be randomized to an USG BP block administered as a single-penetration multiple-injection-technique at one of three different levels: (1) SCL (2) LIC (3) AX. Ropivacaine 0.75% (20 mL) will be used for all blocks prior to surgery.

Interventions

DRUGRopivacaine

20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.

Sponsors

Jens Borglum Neimann
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 18 years * American Society of Anaesthesiology class 1-3 * Patients undergoing upper extremity surgery

Exclusion criteria

* Inability to cooperate * Inability to understand and talk danish * Allergic to ropivacaine * Infection at site of surgery * Neurological dysfunction at site of surgery * Severe coagulopathy * Drug and alcohol abuse * Patients, who can not get a nerve block due to technical difficulty * Pregnancy or nursing * Body mass index \>35

Design outcomes

Primary

MeasureTime frame
Blockade performance time (seconds)Time (seconds) from the time the ultrasound transducer is placed on the skin and until the needle is taken out of the body.

Secondary

MeasureTime frameDescription
Onset time of blockade (minutes)Time from block completion to complete sensory and motor block is accomplished.
Number of needle passesNumber of times the direction of the needle changes while performing the block
Patient reported pain related to needle passes (Scale 0-2)Pain related to block performance reported by the patient right after block completion0= no pain 1. middle 2. sever pain
Duration of time of block postoperatively (hours)Patient reported the time off ending sensory and motory block

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026